{"product_id":"biolegend-100303","title":"Biolegend, 100303, Biotin anti-mouse CD3ε Antibody, 50μg","description":"\u003cp\u003eCD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α\/β or γ\/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide\/MHC antigen complex.\u003cbr\u003e\n50μg\u003cbr\u003e\nVerified Reactivity: Mouse\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Armenian Hamster\u003cbr\u003e\nImmunogen: H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.\u003cbr\u003e\nConcentration: 0.5 mg\/ml\u003cbr\u003e\nStorage \u0026amp; Handling: The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.\u003cbr\u003e\nApplication: FC - Quality testedIHC-F - Verified\u003cbr\u003e\nRecommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl. For immunohistochemistry, a concentration range of 5.0 - 10 µg\/mL is suggested. It is recommended that the reagent be titrated for optimal performance for each application.\u003cbr\u003e\nApplication Notes: Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32, and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin \u0026lt;0.1 EU\/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin \u0026lt;0.01 EU\/µg).\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block) Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ) Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB) Payer E, et al. 1991. J. Immunol. 146:2536. (IF) Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD) Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ) Henrickson M, et al. 1995. Transplantation 60:828. (Deplete) Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete) Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete) Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block) Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ) Ko SY, et al. 2005. J. Immunol. 175:3309. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F) Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F) Wang W, et al. 2007. J. Immunol. 178:4885. (Activ) Xiao S, et al. 2007. J. Exp. Med. 204:1691. Chappaz S, et al. 2007. Blood doi:10.1182\/blood-2007-02-074245. (FC) PubMed. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed Guo Y, et al. 2008. Blood 112:480. PubMed Kenna TJ, et al. 2008. Blood 111:2091. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed Schulteis RD, et al. 2008. Blood 295:G273. PubMed Qi Q, et al. 2009. Blood 114:564. PubMed Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed Yan J, et al. 2014. Vaccine. 32:2833. PubMed Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)\u003cbr\u003e\nProduct Citations: Suzuki M, et al. 2015. J Immunol. 195: 1273-1281. PubMed Doisne J, et al. 2015. J Immunol. 195: 3937 - 3945.. PubMed Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed Obi AT, et al. 2023. Sci Rep. 13:3253. PubMed Miyake K, et al. 2023. Nat Commun. 14:2694. PubMed Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed Song R, et al. 2022. Immunology. 165:274. PubMed Iberg CA, et al. 2022. Cell Rep. 39:110657. PubMed Merana GR, et al. 2022. Cell Rep. 39:110891. PubMed Gupta S, et al. 2022. Sci Adv. 8:eabn4886. PubMed Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed Tomiaki C, et al. 2022. Front Immunol. 13:1014462. PubMed Giannou AD, et al. 2023. Immunity. 56:125. PubMed Gonçalves R, et al. 2023. iScience. 26:105972. PubMed De Giovanni M, et al. 2022. Cell. 185:815. PubMed Davis FM, et al. 2020. J Immunol. 2503:204. PubMed Kim S, et al. 2020. Immunity. 53(4):759-774.e9. PubMed Domingues AF, et al. 2020. Elife. 9:e51754. PubMed Roco JA et al. 2019. Immunity. 51(2):337-350 . PubMed Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed Sasse C, et al. 2022. Pathogens. 11:. PubMed de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed Bowers E, et al. 2018. Nat Med. 24:95. PubMed Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed Lu SX, et al. 2021. Cell. . PubMed Liu X, et al. 2021. eLife. 0.416666666666667. PubMed Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed Mann M, et al. 2018. Cell Rep. 25:2992. PubMed Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed Olsson A, et al. 2016. Nature. 10.1038\/nature19348. PubMed Lim H, et al. 2015. J Immunol. 195: 5432 - 5439. PubMed Kimball A, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1102. PubMed She L, et al. 2021. JCI Insight. 6:e143509. PubMed Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed Kurkewich J, et al. 2016. PLoS One. 11: 0161468. PubMed Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed Köchl R, et al. 2020. Elife. 9:00. PubMed Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed Kimball AS et al. 2019. Immunity. 51(2):258-271 . PubMed Onodera T, et al. 2019. J Immunol. 203:3282. PubMed Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed Kim O, et al. 2017. Nat Commun. 10.1038\/s41467-017-00729-8. PubMed Progatzky F, et al. 2021. Nature. 599:125. PubMed Opejin A, et al. 2020. Cell Reports. 33(8):108424. PubMed Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed , et al. 2021. Eur J Immunol. 51:2708. PubMed Onodera T, et al. 2021. Immunity. 54:2385. PubMed Perez E, et al. 2020. J Immunol. 205:2489. PubMed Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed Blanchard A, et al. 2021. Nat Commun. 12:4693. PubMed Pariser DN, et al. 2021. J Clin Invest. 131:00:00. PubMed Fournier M, Bijl C 2015. Stem Cells Dev. 24: 2413-2422. PubMed Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed Wolf SJ, et al. 2022. JCI Insight. 7:. PubMed Honda H, et al. 2014. J Leukoc Biol. 96:1087. PubMed Liao G, et al. 2010. Int Immunol. 1.096527778. PubMed Zeis P, et al. 2020. Immunity. 53:775. PubMed Kimball AS, et al. 2020. Thromb Haemost. 120:289. PubMed Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed Murata T, et al. 2020. Sci Rep. 10:13560. PubMed Koide S, et al. 2022. iScience. 25:103603. PubMed Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed Park DS, et al. 2019. PLoS Comput Biol. 15:e1006913. PubMed Yoshida H, et al. 2019. Cell. 176:897. PubMed Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed Anderson DA, et al. 2022. J Exp Med. 219:. PubMed Wagner AK, et al. 2022. iScience. 25:105137. PubMed Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed Lutz J, et al. 2015. Nat Commun. 6: 8575. PubMed Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed Luo H, et al. 2019. Cell Rep. 26:945. PubMed Ho K, et al. 2014. Cell Death Dis. 5:1518. PubMed Bieber K, et al. 2016. Sci Rep. 6:38357. PubMed Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed O'Boyle C, et al. 2020. Int J Stroke. 0.746527778. PubMed Bae S, et al. 2021. Cell Reports. 35(11):109264. PubMed Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed Muro R, et al. 2015. PLoS One. 10:119898. PubMed Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed Deets KA, et al. 2021. Elife. 10:. PubMed Celias DP, et al. 2022. STAR Protoc. 3:101464. PubMed Davis FM, et al. 2021. J Exp Med. 218:. PubMed\u003cbr\u003e\nRRID: AB_312668 (BioLegend Cat. No. 100303) AB_312669 (BioLegend Cat. No. 100304)\u003cbr\u003e\nStructure: Ig superfamily, forms CD3\/TCR complex with CD3δ, γ and ζ subunits and TCR (α\/β and γ\/δ), 20 kD\u003cbr\u003e\nDistribution: Thymocytes (differentiation dependent), mature T cells, NK-T cells\u003cbr\u003e\nFunction: TCR signal transduction, T cell activation, antigen recognition\u003cbr\u003e\nLigand\/Receptor: Peptide antigen\/MHC-complex\u003cbr\u003e\nCell Type: NKT cells, T cells, Thymocytes, Tregs\u003cbr\u003e\nBiology Area: Immunology\u003cbr\u003e\nMolecular Family: CD Molecules, TCRs\u003cbr\u003e\nAntigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Davis MM. 1990. Annu. Rev. Biochem. 59:475. 3. Weiss A, et al. 1994. Cell 76:263.\u003cbr\u003e\nGene ID: 12501\u003cbr\u003e\nUniProt: View information about CD3epsilon on UniProt.org\u003cbr\u003e\nClone: 145-2C11\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nOther Names: CD3ε, T3, CD3\u003cbr\u003e\nIsotype: Armenian Hamster IgG\u003cbr\u003e\nQ: How many biotin molecules are per antibody structure?\u003cbr\u003e\nA: We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46860803408041,"sku":"100303","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/ar\/products\/biolegend-100303","provider":"Iright","version":"1.0","type":"link"}